# Stryker and CMR Surgical announce strategic alliance for robotic-assisted surgery

Stryker will make an approximately $400 million preferred equity investment in CMR Surgical, with an exclusive option to acquire 100% of CMR Surgical in the future. Stryker will serve as the exclusive U.S. sales agent for the Versius surgical robotic portfolio.

- Type: Partnership
- Announced: 2026-10-12
- Value: $400.0M
- Status: announced
- Products: Versius surgical robotic system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Automation and Robotics](https://endata.com/sectors/automation-robotics.md)

## Companies

- [Stryker](https://endata.com/companies/15355.md) (investor)
- [CMR Surgical](https://endata.com/companies/15356.md) (partner)

## Sources

- [stryker.com](https://www.stryker.com/ca/en/about/news/2026/stryker-cmr-surgical-announce-strategic-alliance-advance-robotic-assisted-surgery.html), 2026-10-12: "Stryker will make an approximately $400 million (£300 million) preferred equity investment in CMR Surgical to support future innovation and global commercialization of the Versius portfolio."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.